请使用支持JavaScript的浏览器!
主营:抗体及重组蛋白
℡ 4000-520-616
℡ 4000-520-616
ProteinTech/Phospho-AKT (Ser473) Monoclonal antibody/150ul/66444-1-Ig
产品编号:66444-1-Ig
市  场 价:¥1980.00
场      地:美国(厂家直采)
产品分类: 蛋白类>多肽>多肽合成>
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$99.00
品      牌: ProteinTech
公      司:Proteintech Group, Inc
公司分类:
ProteinTech/Phospho-AKT (Ser473) Monoclonal antibody/150ul/66444-1-Ig
商品介绍

Tested Applications

Positive WB detected inCalyculin A treated HEK-293T cells, HEK-293 cells,Jurkat cells,Calyculin A treated PC-3 cells,TPA treated Jurkat cells
Positive IHC detected inhuman breast cancer tissueNote: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
Immunohistochemistry (IHC)IHC : 1:100-1:400
Sample-dependent, check data in validation data gallery

Published Applications

WBSee 200 publications below
IHCSee 22 publications below
IFSee 1 publications below

Product Information

66444-1-Ig targets Phospho-AKT (Ser473) inWB, IHC, IF, ELISA applications and shows reactivity with human,mouse samples.

Tested Reactivityhuman,mouse
Cited Reactivity chicken, human, mouse, rat
Host / IsotypeMouse / IgG1
ClassMonoclonal
TypeAntibody
ImmunogenPeptide
Full Namev-akt murine thymoma viral oncogene homolog 1
Observed molecular weight 60-62 kDa
GenBank accession numberNM_005163
Gene symbolAKT1
Gene ID (NCBI)207
ConjugateUnconjugated
FormLiquid
Purification MethodProtein A purification
Storage BufferPBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for-20oC storage.

Background Information

1) What is AKT?

The serine/threonine kinase B AKT pathway (also known as the PI3K-Akt pathway) plays a vital role in the regulation of cellular processes, including cell proliferation, survival, and growth – processes that are essential for oncogenesis. Mutation of the regulator proteins PI3K and PTEN causes uncontrolled disruption within the PI3-kinase pathway, leading to the development of human cancers (1,2; see also AKT pathway poster for more details).

2) phospho-AKT and FAQs

A) What is the best way to normalize phosphorylated proteins analyzed by western blot?Normalize phospho-AKT and total AKT with your loading control (e.g. Actin, tubulin), then calculate the phospho/total ratio using these normalized values. Put more simply:1. Calculate the ratio of band intensities of a phospho-AKT band: the loading control.2. Calculate the ratio of band intensities of total AKT: loading control.3. Divide ratio obtained #1 by #2 to obtain a normalized value for comparison among different conditions. This procedure allows one to distinguish between a change in AKT expression and a change in the ratio of phospho-AKT.* If you are looking at the differences in a phospho-AKT expression resulting from an experimental condition (e.g., knockdown), you should also show the expression of total AKT to distinguish between a change in AKT expression (transcription/translation level) and a change in the AKT phosphorylation status.B) What is the observed molecular weight for AKT and phospho-AKT?Molecular Weight AKT – 56 kDaMolecular Weight phospho-AKT – 60 kDa (Figure 1)

Figure 1. WB: HEK-293 cell lysate was subjected to SDS PAGE followed by western blot with 60203-2-Ig (AKT antibody) and 66444-1-Ig (AKT-phospho-S473 antibody) at a dilution of 1:4000 incubated at room temperature for 1.5 hours.

C) Are there any special WB conditions to optimize staining of a phospho-AKT?Since this is a phosphorylated protein, 5% BSA is recommended over non-fat milk as a blocking agent.D) What are good positive and negative controls for a phospho-AKT?- Positive Control: HEK293 cells- Negative Control: Treatment with PI3K inhibitors (e.g. wortmannin)E) What species does this antibody react with?

Our internal testing has confirmed that it reacts with the human and mouse forms of phospho-AKT.Reactivity with the human form is also supported by the literature’s citations of this antibody.

References:

1. Perturbations of the AKT signaling pathway in human cancer.2. Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Protocols

Product Specific Protocols
WB protocol for Phospho-AKT (Ser473) antibody 66444-1-IgDownload protocol
IHC protocol for Phospho-AKT (Ser473) antibody 66444-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
品牌介绍

Proteintech是一家以研发、生产、销售抗体/重组蛋白及相关 产品为主要业务的生物技术公司。拥有严格的抗体生产、质检质控体系,产品涵盖整个生命科学领域。Proteintech作为全球最大的专业抗体生产 商之一,凭借一支锐意进取的技术团队和稳定的技术平台,已研发和生产出14000多种特种抗体和14000多种人源蛋白产品。2018年4月正式收 购首家人源细胞生产人类蛋白的Humanzyme公司,新增Humankine高活性人源蛋白产品系列。目前,Proteintech已建立全球市场销售网络, 美国、欧洲、中国和日本均有现货库存,全球24小时现货发售。



2001

Proteintech在美国创立


2003.8

使用Proteintech产品的第一篇文献发表


2004

在中国武汉成立中国分公司;第100个抗体成功生产



2001

Proteintech在美国创立


2003.8

使用Proteintech产品的第一篇文献发表


2004

在中国武汉成立中国分公司;第100个抗体成功生产


2006.4

第一个单克隆抗体上线销售


2007

在英国曼彻斯特成立欧洲分公司;使用Proteintech产品的发表文章达到50篇


2008

使用Proteintech产品的发表文章达到100篇



2001

Proteintech在美国创立


2003.8

使用Proteintech产品的第一篇文献发表


2004

在中国武汉成立中国分公司;第100个抗体成功生产


2006.4

第一个单克隆抗体上线销售


2007

在英国曼彻斯特成立欧洲分公司;使用Proteintech产品的发表文章达到50篇


2008

使用Proteintech产品的发表文章达到100篇


2010

使用Proteintech产品的发表文章达到1000篇


2012.3.3

第一个ELISA试剂盒上线销售;欧洲分公司获得ISO9001认证


2013

新实验室成立;使用Proteintech产品的发表文章达到5000篇


2001

Proteintech在美国创立


2003.8

使用Proteintech产品的第一篇文献发表


2004

在中国武汉成立中国分公司;第100个抗体成功生产


2006.4

第一个单克隆抗体上线销售


2007

在英国曼彻斯特成立欧洲分公司;使用Proteintech产品的发表文章达到50篇


2008

使用Proteintech产品的发表文章达到100篇


2010

使用Proteintech产品的发表文章达到1000篇


2012.3.3

第一个ELISA试剂盒上线销售;欧洲分公司获得ISO9001认证


2013

新实验室成立;使用Proteintech产品的发表文章达到5000篇


2014

获得SPF鼠房认证以及ISO9001以及ISO13485认证


2015.1

内部siRNA部门正式成立;使用Proteintech产品的文章达到10000篇


2018

Proteintech acquires Humanzyme, manufacturer of human-cell expressed proteins.



2001

Proteintech在美国创立


2003.8

使用Proteintech产品的第一篇文献发表


2004

在中国武汉成立中国分公司;第100个抗体成功生产


2006.4

第一个单克隆抗体上线销售


2007

在英国曼彻斯特成立欧洲分公司;使用Proteintech产品的发表文章达到50篇


2008

使用Proteintech产品的发表文章达到100篇


2010

使用Proteintech产品的发表文章达到1000篇


2012.3.3

第一个ELISA试剂盒上线销售;欧洲分公司获得ISO9001认证


2013

新实验室成立;使用Proteintech产品的发表文章达到5000篇


2014

获得SPF鼠房认证以及ISO9001以及ISO13485认证


2015.1

内部siRNA部门正式成立;使用Proteintech产品的文章达到10000篇


2018

Proteintech acquires Humanzyme, manufacturer of human-cell expressed proteins.

 

现在

Proteintech的产品已经达到12000多种,通过直销以及授权分销体系,产品覆盖五大洲55个国家。


自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔